Home
SAVA
SAVA News

Latest Cassava Sciences Inc. (SAVA) News on January 19, 2025

MT Newswires

11 days ago

Cassava Sciences to Reduce Staff, Halt Further Analysis

Cassava Sciences Provides a Business Update

GlobeNewswire

12 days ago

Cassava Sciences Provides a Business Update

Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More

Zacks

2 months ago

Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More

Zacks

2 months ago

A Post-Mortem on Cassava Sciences

SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage Study

Zacks

2 months ago

SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage Study

Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)

Zacks

2 months ago

Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)

MT Newswires

2 months ago

Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Tuesday; Cassava Sciences to Advance, MicroStrategy to Decline

Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops

Investor's Business Daily

2 months ago

Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops

Cassava Sciences plummets over 80% on Alzheimer's trial fail

Yahoo Finance Video

2 months ago

Cassava Sciences plummets over 80% on Alzheimer's trial fail

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise in Monday Afternoon Trading

Cassava Sciences stock plummets after Phase III Alzheimer’s fail

Clinical Trials Arena

2 months ago

Cassava Sciences stock plummets after Phase III Alzheimer’s fail

Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops

FastCompany

2 months ago

Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops

Cassava Sciences Stock Slides 84% as Alzheimer’s Trial Fails

Barrons.com

2 months ago

Cassava Sciences Stock Slides 84% as Alzheimer’s Trial Fails

Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies

Benzinga

2 months ago

Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies

Cassava Stock Plunges as Alzheimer's Drug Fails Late-Stage Study

Investopedia

2 months ago

Cassava Stock Plunges as Alzheimer's Drug Fails Late-Stage Study

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

Cassava Sciences Plummets 85% After Embattled Alzheimer's Drug Flops

Investor's Business Daily

2 months ago

Cassava Sciences Plummets 85% After Embattled Alzheimer's Drug Flops

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Cassava Sciences Simufilam Misses Endpoints in Late-Stage Alzheimer's Trial; Shares Drop Pre-Bell

Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints

GlobeNewswire

2 months ago

Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints

Cassava Sciences to Hold Corporate Update on November 25th

GlobeNewswire

2 months ago

Cassava Sciences to Hold Corporate Update on November 25th

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer

GlobeNewswire

2 months ago

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer

Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?

What Makes Cassava Sciences (SAVA) a New Buy Stock

Zacks

2 months ago

What Makes Cassava Sciences (SAVA) a New Buy Stock

Cassava Sciences Reports Q3 2024 Financial and Operating Results

GlobeNewswire

2 months ago

Cassava Sciences Reports Q3 2024 Financial and Operating Results

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

GlobeNewswire

3 months ago

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value

Simply Wall St.

3 months ago

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value

MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain

Benzinga

3 months ago

MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain

Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge

Insider Monkey

3 months ago

Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge

Cassava Sciences Advances Alzheimer’s Trials Amid SEC Settlement

TipRanks

3 months ago

Cassava Sciences Advances Alzheimer’s Trials Amid SEC Settlement

Cassava Sciences: Phase III trials storm ahead amid controversy

Clinical Trials Arena

3 months ago

Cassava Sciences: Phase III trials storm ahead amid controversy

MT Newswires

3 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

3 months ago

Cassava Sciences Completes Phase 3 ReTHINK Alzheimer's Trial

What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday?

Benzinga

3 months ago

What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday?

SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims

Zacks

4 months ago

SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims

Company News for Sep 30, 2024

Zacks

4 months ago

Company News for Sep 30, 2024

Why Cassava Sciences Stock Dived by Almost 11% Today

Motley Fool

4 months ago

Why Cassava Sciences Stock Dived by Almost 11% Today

These Stocks Moved the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More

Barrons.com

4 months ago

These Stocks Moved the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More

Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims

Yahoo Finance Video

4 months ago

Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims

MT Newswires

4 months ago

Top Midday Decliners

Cassava's Stock Drops After It Agrees to Pay $40M to Settle SEC Alzheimer's Claims

Investopedia

4 months ago

Cassava's Stock Drops After It Agrees to Pay $40M to Settle SEC Alzheimer's Claims

MT Newswires

4 months ago

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday

Investing.com

4 months ago

Cassava Sciences shares drop in pre-open trade after $40 mln SEC settlement

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava Sciences, Trump Media, HP Inc., and More

Barrons.com

4 months ago

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava Sciences, Trump Media, HP Inc., and More

SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty

Benzinga

4 months ago

SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty

MT Newswires

4 months ago

Update: Cassava Sciences Pays $40 Million to Settle SEC Charges; Shares Drop Pre-Bell

MT Newswires

4 months ago

Cassava Sciences Pays $40 Million to Settle SEC Charges

Cassava to Pay $40 Million to SEC Over Alzheimer’s Drug Claims

Bloomberg

4 months ago

Cassava to Pay $40 Million to SEC Over Alzheimer’s Drug Claims

Cassava Sciences Resolves SEC Investigation

GlobeNewswire

4 months ago

Cassava Sciences Resolves SEC Investigation

Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims

Reuters

4 months ago

Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims

Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan

Zacks

4 months ago

Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

GlobeNewswire

4 months ago

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

MT Newswires

4 months ago

Cassava Sciences Names Richard Barry CEO, Appoints Claude Nicaise as Board Chairman

Cassava Sciences Names Rick Barry as Chief Executive Officer

GlobeNewswire

4 months ago

Cassava Sciences Names Rick Barry as Chief Executive Officer

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire

5 months ago

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

Silicon Motion Technology Corporation (SAVA): Evaluating Its Position Among Top Debt-Free Stocks

Insider Monkey

5 months ago

Silicon Motion Technology Corporation (SAVA): Evaluating Its Position Among Top Debt-Free Stocks

Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near?

Simply Wall St.

5 months ago

Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near?

MT Newswires

5 months ago

Cassava Sciences Shares Drop on Estimated $40 Million Charge in H2 to Resolve US SEC Probe

Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates

GlobeNewswire

5 months ago

Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates

Reuters

5 months ago

Biotech firm drops defamation suit against short-sellers after researcher charged

Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson

GlobeNewswire

5 months ago

Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson

Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET

GlobeNewswire

6 months ago

Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET

Cassava Sciences Announces Expansion of Open-Label Extension Trials

GlobeNewswire

6 months ago

Cassava Sciences Announces Expansion of Open-Label Extension Trials

MT Newswires

6 months ago

Cassava Shares Rise After Incoming Chairman Gives Timeline for Alzheimer's Drug Study Read Out

Why Cassava Sciences Stock Is Skyrocketing Today

Motley Fool

6 months ago

Why Cassava Sciences Stock Is Skyrocketing Today

MT Newswires

6 months ago

Cassava Sciences Shares Rise After Court Schedules Hearing on Bonus Plan Lawsuit Settlement

Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates

Zacks

6 months ago

Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates

MT Newswires

6 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials

Benzinga

6 months ago

Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials

MT Newswires

6 months ago

Top Midday Decliners

MT Newswires

6 months ago

Cassava Sciences Names Richard Barry Executive Chairman, Launches Search for CEO

Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

GlobeNewswire

6 months ago

Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

Cassava forms committee after US probe, researcher fraud

Yahoo Finance Video

7 months ago

Cassava forms committee after US probe, researcher fraud

Stocks to Watch Monday: Chewy, Boeing, NIO, Cassava Sciences

The Wall Street Journal

7 months ago

Stocks to Watch Monday: Chewy, Boeing, NIO, Cassava Sciences

Why Cassava Sciences Stock Is Sinking Today

Motley Fool

7 months ago

Why Cassava Sciences Stock Is Sinking Today

MT Newswires

7 months ago

Top Premarket Gainers

Investing.com

7 months ago

Spirit Aerosystems, Tesla and Chewy rise premarket; GameStop, Boeing fall

Cassava Sciences Shares Plunge on Indictment Against Former Advisor

Barrons.com

7 months ago

Cassava Sciences Shares Plunge on Indictment Against Former Advisor

Cassava Sciences Adviser Indicted on Fraud Charges

The Wall Street Journal

7 months ago

Cassava Sciences Adviser Indicted on Fraud Charges

Cassava Sciences Issues Statement on Former Science Advisor

GlobeNewswire

7 months ago

Cassava Sciences Issues Statement on Former Science Advisor

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

7 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

7 months ago

Form 8.3 - International Distribution Services plc

Business Wire

7 months ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

7 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

7 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

7 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

GlobeNewswire

7 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

Business Wire

7 months ago

Form 8.3 - International Paper Company

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

7 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

7 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

7 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

7 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

7 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

7 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

7 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

7 months ago

Enduring role of 'treasuring the past' hailed

Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross

Zacks

8 months ago

Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam

GlobeNewswire

8 months ago

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam

MT Newswires

8 months ago

Cassava Sciences Raises More Than $125 Million From Warrant Distribution

Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution

GlobeNewswire

8 months ago

Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution

Share on Social Networks: